Cimzia 2X200 MG/ML syringe kits
Ended Awarded Last action
- Contract number
- SPE2DR26F9NJ8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,597
Award facts
- Contract value 100% obligated
- $27,596.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,596.52 to AmerisourceBergen Drug Corp for the supply of CIMZIA 2x200 mg/ml syringe kits. This firm fixed-price, non-set-aside contract was awarded on January 28, 2026, with an ultimate completion date of January 29, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CIMZIA is a pharmaceutical treatment used in the management of inflammatory conditions, and this delivery order represents a specific task order fulfillment under a larger contracting vehicle.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This prime indefinite delivery contract serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's non-set-aside competitive award demonstrates the company's continued capability to meet federal procurement requirements for critical pharmaceutical commodities supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9NJ8?
SPE2DR26F9NJ8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F9NJ8 worth?
The government has obligated $27,597 on SPE2DR26F9NJ8.
Is contract SPE2DR26F9NJ8 an order under another contract?
Yes. SPE2DR26F9NJ8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NJ8 competed?
The extent of competition for SPE2DR26F9NJ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award